What is BioMarin Pharmaceuticals's europe — revenue?

BioMarin Pharmaceuticals (BMRN) reported europe — revenue of $115.5M in Q3 2021.

What does europe — revenue mean?

The total amount of money earned from product sales in European countries.

How do you interpret europe — revenue?

An increase indicates successful market expansion, strong product adoption, or favorable pricing in Europe, while a decrease may signal competitive pressure, regulatory hurdles, or reimbursement challenges.

How does europe — revenue compare across companies?

Comparable to regional revenue reporting for other multinational biopharmaceutical companies, often benchmarked against total international revenue growth rates.

BioMarin Pharmaceuticals BMRN Europe — Revenue

Discontinued — last reported Q3 '21

Similar metrics at other companies

MRNAEurope — Total Revenue

$13.25M-91.1%

SMMTEurope — Revenue

$0—

KRYSEurope — Product revenue, net

$20.68M—

ILMNEurope — Revenue

$353M+8.3%

INCYEurope — Total revenues

$92.43M+34.7%

EXELEurope — Total revenues

$39.57M+21.0%

Other financials

Income statement

See full

Revenue$766.2M+2.8%

Gross profit$571.2M-3.8%

Operating income$129.6M-42.1%

Net income$105.5M-43.2%

EPS (diluted)$0.54-43.2%

Balance sheet

See full

Cash & equivalents$3.1B+193%

Total debt$1.4B+138%

Total equity$6.2B+7.2%

Total assets$8.6B+20.2%

Cash flow

See full

Operating cash flow$220.7M+26.5%

CapEx$20.9M+24.8%

Free cash flow$199.7M+26.7%

Valuation

See full

Market cap$10.57B-19.4%

Enterprise value$8.93B-29.3%

P/E21.1×-22.7×

P/S3.3×-1.2×

Profitability

See full

Gross margin76.5%-2.9pp

Operating margin19.9%+7.2pp

Net margin16.8%+5.1pp

FCF margin23.7%+2.5pp

Returns & leverage

See full

Return on equity9.1%+2.8pp

Debt / equity0.2×+0.1×

Current ratio5.8×+0.3×

Where this comes from

Reported directly by BioMarin Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: BioMarin Pharmaceuticals’s 10-Q, filed October 29, 2021, on SEC EDGAR. View the filing →

Ask your AI about BioMarin Pharmaceuticals's europe — revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BioMarin Pharmaceuticals's europe — revenue?: BioMarin Pharmaceuticals (BMRN) reported europe — revenue of $115.5M in Q3 2021.
What does europe — revenue mean?: The total amount of money earned from product sales in European countries.
How do you interpret europe — revenue?: An increase indicates successful market expansion, strong product adoption, or favorable pricing in Europe, while a decrease may signal competitive pressure, regulatory hurdles, or reimbursement challenges.
How does europe — revenue compare across companies?: Comparable to regional revenue reporting for other multinational biopharmaceutical companies, often benchmarked against total international revenue growth rates.